PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

 366.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 425.50
  • 52 Week Low: 237.50
  • Currency: UK Pounds
  • Shares Issued: 286.55m
  • Volume: 0
  • Market Cap: £1,048.78m

PureTech sells down Karuna stake as Vor closes IPO

By Josh White

Date: Wednesday 10 Feb 2021

LONDON (ShareCast) - (Sharecast News) - Clinical-stage biotherapeutics commercialisation company PureTech Health announced on Wednesday that its founded entity Vor Biopharma has closed its initial public offering at a price of $18 per share.
At the same time, the company announced that it sold one million shares of founded entity Karuna Therapeutics through a block trade executed by Morgan Stanley, for cash of around $118m.

The FTSE 250 firm said that the Vor IPO consisted of 9,828,017 common shares, and an additional 1,474,202 shares sold under the full option exercised by the underwriters.

"The aggregate gross proceeds to Vor from the offering, before deducting the underwriting discounts and commissions and other offering expenses payable by Vor, were approximately $203.4m," the board said in its statement.

The shares began trading on the Nasdaq Global Market on 5 February under the ticker symbol 'VOR'.

Following the closing, PureTech said it held 3,207,200 shares of Vor common stock.

Looking at the Karuna selldown, PureTech said it intended to use the proceeds to further expand and advance its clinical-stage wholly-owned pipeline.

"PureTech intends to update financial guidance in connection with the issuance of its 2020 annual report and accounts later this year," the board said.

At 0917 GMT, shares in PureTech Health were down 0.66% at 375p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 366.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 425.50
52 Week Low 237.50
Volume 0
Shares Issued 286.55m
Market Cap £1,048.78m

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.75% below the market average15.75% below the market average15.75% below the market average15.75% below the market average15.75% below the market average
36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average
Price Trend
8.47% above the market average8.47% above the market average8.47% above the market average8.47% above the market average8.47% above the market average
6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average
Income Not Available
Growth
88.83% below the market average88.83% below the market average88.83% below the market average88.83% below the market average88.83% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

PRTC Key Personnel

CEO Daphne Zohar
Chair Christopher Viehbacher

Top of Page